InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Ondrey Aaron. Director active across 2 companies, notably Mirati Therapeutics, Inc.. In total, 6 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. History available since 8 September 2023. The latest transaction was disclosed on 4 April 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations